Rate Cuts Table Outlook: 2 Stocks Under $30 Ready Now
With the rate cuts table still unsettled, contrarian investors are targeting under-$30 names with strong balance shee...
This tag page curates 5 Healthcare Stocks articles to help you assess risks, dividend potential, and notable moves from Chemed to UnitedHealth, helping smarter investment decisions.
57 articlesWith the rate cuts table still unsettled, contrarian investors are targeting under-$30 names with strong balance shee...
In a market where dividends among healthcare firms can be elusive, two names stand out for investors seeking income n...
When a stock stalls, a disciplined fund can still see value in the long run. This article explains why this fund made...
U.S. healthcare equities rise as firms deploy agentic AI to cut labor costs, lifting a group of AI-enabled healthcare...
CVS Health posts a robust Q1 driven by Aetna, lifting guidance and reigniting investor optimism. The market now weigh...
When a top bank places a stock on its conviction list, it moves markets. This article explains why Goldman Sachs just...
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
Pacs Group stock surged after the healthcare facility operator released solid quarterly results. Strong revenue growt...
Si-Bone stock soared almost 20% on Tuesday as investors reacted to strong quarterly results and optimistic guidance. ...
Harrow Health's Q1 2026 earnings transcript offers more than numbers—it reveals management's execution plan and what ...
Pfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
An investor's guide to the early signals from hims 2026 earnings. We break down Q1 results, margins, and what they me...